Altogether, results indicate that GSK-J4 is effective to reduce proliferation in all tested PCa cell lines and the CRPC cell lines are more sensitive to the treatment than AR-WT expressing PCa cell lines. This evidence concerns the gene AR and posterior cortical atrophy.